Does AREDIA Cause Malignant neoplasm progression? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Malignant neoplasm progression have been filed in association with AREDIA. This represents 26.7% of all adverse event reports for AREDIA.
44
Reports of Malignant neoplasm progression with AREDIA
26.7%
of all AREDIA reports
21
Deaths
32
Hospitalizations
How Dangerous Is Malignant neoplasm progression From AREDIA?
Of the 44 reports, 21 (47.7%) resulted in death, 32 (72.7%) required hospitalization, and 1 (2.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AREDIA. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does AREDIA Cause?
Osteonecrosis of jaw (151)
Pain (128)
Anxiety (122)
Spinal osteoarthritis (114)
Osteoarthritis (113)
Dyspnoea (107)
Arthralgia (102)
Osteomyelitis (95)
Anaemia (89)
Atelectasis (89)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which AREDIA Alternatives Have Lower Malignant neoplasm progression Risk?
AREDIA vs ARFORMOTEROL
AREDIA vs ARGATROBAN
AREDIA vs ARGININE
AREDIA vs ARGININE\LYSINE
AREDIA vs ARIMIDEX